The urgency of resuming disrupted dog rabies vaccination campaigns: a modeling and cost-effectiveness analysis

被引:0
|
作者
Amber Kunkel
Seonghye Jeon
Haim C. Joseph
Pierre Dilius
Kelly Crowdis
Martin I. Meltzer
Ryan Wallace
机构
[1] Centers for Disease Control and Prevention,Poxvirus and Rabies Branch, Division of High
[2] Centers for Disease Control and Prevention,Consequence Pathogens and Pathology, National Center for Emerging & Zoonotic Infectious Diseases
[3] Centers for Disease Control and Prevention,Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services
[4] Ministry of Agriculture,Emergency Preparedness and Response Branch, Division of Preparedness and Emerging Infections, National Center for Emerging & Zoonotic Infectious Diseases
[5] Rural Development,undefined
[6] and Natural Resources,undefined
[7] Christian Veterinary Mission,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Dog vaccination is a cost-effective approach to preventing human rabies deaths. In Haiti, the last nation-wide dog vaccination campaign occurred in 2018. We estimated the number of human lives that could be saved by resuming dog vaccination in 2021 compared to 2022 and compared the cost-effectiveness of these two scenarios. We modified a previously published rabies transmission and economic model to estimate trends in dog and human rabies cases in Haiti from 2005 to 2025, with varying assumptions about when dog vaccinations resume. We compared model outputs to surveillance data on human rabies deaths from 2005 to 2020 and animal rabies cases from 2018 to 2020. Model predictions and surveillance data both suggest a 5- to 8-fold increase in animal rabies cases occurred in Haiti’s capital city between Fall 2019 and Fall 2020. Restarting dog vaccination in Haiti in 2021 compared to 2022 could save 285 human lives and prevent 6541 human rabies exposures over a five-year period. It may also decrease program costs due to reduced need for human post-exposure prophylaxis. These results show that interruptions in dog vaccination campaigns before elimination is achieved can lead to significant human rabies epidemics if not promptly resumed.
引用
收藏
相关论文
共 50 条
  • [41] Evaluating the Cost-Effectiveness of Vaccination Programs
    Elbasha, Elamin H.
    Dasbach, Erik J.
    MATHEMATICS OF CONTINUOUS AND DISCRETE DYNAMICAL SYSTEMS, 2014, 618 : 17 - 47
  • [42] Cost-effectiveness of rotavirus vaccination in Turkey
    Koksal, Tulin
    Akelma, Ahmet Zulfikar
    Koksal, Ali Osman
    Kutukoglu, Irem
    Ozdemir, Osman
    Yuksel, Cigdem Nuket
    Bozkaya, Davut
    Catal, Ferhat
    Sari, Sinan
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2017, 50 (05) : 693 - 699
  • [43] Cost-effectiveness of Rotavirus vaccination in Vietnam
    Sun-Young Kim
    Sue J Goldie
    Joshua A Salomon
    BMC Public Health, 9
  • [44] Cost-effectiveness of hepatitis A vaccination in Indonesia
    Suwantika, Auliya A.
    Beutels, Philippe
    Postma, Maarten J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (08) : 2342 - 2349
  • [45] Cost-effectiveness of rotavirus vaccination in Mozambique
    Guimaraes, Esperanca Lourenco
    Chissaque, Assucenio
    Pecenka, Clint
    Clark, Andrew
    Vaz, Basilia
    Banze, Arlindo
    Canana, Neide
    Romao, Clesio
    Martins, Maria do Rosario Oliveira
    de Deus, Nilsa
    Debellut, Frederic
    VACCINE, 2022, 40 (36) : 5338 - 5346
  • [46] Cost-effectiveness of rotavirus vaccination in Albania
    Ahmeti, Albana
    Preza, Iria
    Simaku, Artan
    Nelaj, Erida
    Clark, Andrew David
    Garcia, Ana Gabriela Felix
    Lara, Carlos
    Hoestlandt, Celine
    Blau, Julia
    Bino, Silvia
    VACCINE, 2015, 33 : A201 - A208
  • [47] Cost-effectiveness of adult pneumococcal vaccination
    Grabenstein, John D.
    O'Brien, Megan A.
    Chen, Jieling
    VACCINE, 2013, 31 (12) : 1549 - 1549
  • [48] Cost-effectiveness of Rotavirus vaccination in Vietnam
    Kim, Sun-Young
    Goldie, Sue J.
    Salomon, Joshua A.
    BMC PUBLIC HEALTH, 2009, 9
  • [49] The cost-effectiveness of rotavirus vaccination in Belgium
    Bilcke, J.
    Beutels, P.
    Van Damme, P.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2007, 17 : 179 - 180
  • [50] THE COST-EFFECTIVENESS OF VARICELLA VACCINATION IN PERU
    Blas, M.
    Gutierrez, R.
    Petrozzi, V
    Monsanto, H.
    Best, P.
    Pillsbury, M.
    Weiss, T. J.
    Pavelyev, A.
    Wolfson, L. J.
    VALUE IN HEALTH, 2017, 20 (09) : A942 - A942